BioPorto A/S (BIOPOR.CO) Free Cash Flow
Market Cap: $610.11M
Avg Volume: 374.04K
Industry: Medical - Diagnostics & Research
Sector: Healthcare
What is BioPorto A/S's Free Cash Flow?
- BioPorto A/S's annual free cash flow as of FY 2023 is $-55.49M.
- BioPorto A/S's quarterly free cash flow as of QQ3 2024 is $-26.27M.
What is Free Cash Flow?
Free cash flow (FCF) is a measure of financial performance calculated as operating cash flow minus capital expenditures. It represents the cash that a company generates after accounting for cash outflows to support operations and maintain its capital assets. FCF is important because it allows a company to pursue opportunities that enhance shareholder value.
How is Free Cash Flow calculated?
The formula for free cash flow is:
Free Cash Flow = Operating Cash Flow - Capital Expenditures
This metric helps investors understand the company's ability to generate cash and its potential to pay dividends or expand.
Related Metrics
Other important metrics to assess BioPorto A/S's free cash flow financial health include:
- Free Cash Flow Growth - the rate at which a company's free cash flow is growing:
- Annual Growth: -4.79%
- Free Cash Flow Per Share - free cash flow divided by the number of shares outstanding:
- Annual: $-0.15
- Free Cash Flow Yield - free cash flow divided by the market capitalization:
- Annual: -7.41%
These metrics provide insights into BioPorto A/S's financial health and its ability to generate cash. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Free Cash Flow
$-55.49M
Quarterly Free Cash Flow
$-26.27M
Historical Annual Free Cash Flow
Historical Quarterly Free Cash Flow
Annual Free Cash Flow Growth
Annual Free Cash Flow Per Share
BioPorto A/S Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | Free Cash Flow | Free Cash Flow Growth | Free Cash Flow Per Share | Free Cash Flow Yield |
|---|---|---|---|---|
| 2023 | $-55.49M | -4.79% | $-0.15 | -7.41% |
| 2022 | $-52.96M | 18.49% | $-0.16 | -6.89% |
| 2021 | $-64.97M | -75.04% | $-0.23 | -9.46% |
| 2020 | $-37.12M | 39.42% | $-0.17 | -4.30% |
| 2019 | $-61.27M | -55.23% | $-0.24 | -8.19% |
| 2018 | $-39.47M | -34.09% | $-0.20 | -5.24% |
| 2017 | $-29.44M | -47.06% | $-0.16 | -4.90% |
| 2016 | $-20.02M | -17.14% | $-0.12 | -5.78% |
| 2015 | $-17.09M | -0.84% | $-0.11 | -2.31% |
| 2014 | $-16.95M | -1.66% | $-0.11 | -6.76% |
Related Metrics
Explore detailed financial metrics and analysis for BIOPOR.CO.